CHICAGO, Dec 7 (Reuters) - A top U.S. scientist overseeing COVID-19 vaccine trials expects a large U.S. study to determine how effective AstraZeneca's experimental inoculation is, following perplexing ...
Tell us about the work you lead at AstraZeneca. I work on the development of inhalation devices for patients, mostly with COPD and asthma. There are a couple of different kinds of inhalers we are ...
" This next phase of work for AstraZeneca gives us a valuable opportunity to examine how international real-world data is being operationalized in regulatory submissions, not just conceptually, but in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results